• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于疾病建模和表型药物发现的患者特异性诱导多能干细胞。

Patient-Specific Induced Pluripotent Stem Cells for Disease Modeling and Phenotypic Drug Discovery.

机构信息

Gladstone Institutes , 1650 Owens Street, San Francisco, California 94158, United States.

出版信息

J Med Chem. 2016 Jan 14;59(1):2-15. doi: 10.1021/acs.jmedchem.5b00789. Epub 2015 Sep 4.

DOI:10.1021/acs.jmedchem.5b00789
PMID:26322868
Abstract

In vitro cell models are invaluable tools for studying diseases and discovering drugs. Human induced pluripotent stem cells, particularly derived from patients, are an advantageous resource for generating ample supplies of cells to create unique platforms that model disease. This manuscript will review recent developments in modeling a variety of diseases (including their cellular phenotypes) with induced pluripotent stem cells derived from patients. It will also describe how researchers have exploited these models to validate drugs as potential therapeutics for these devastating diseases.

摘要

体外细胞模型是研究疾病和发现药物的宝贵工具。人类诱导多能干细胞,特别是从患者中获得的诱导多能干细胞,是产生大量细胞的有利资源,可创建独特的平台来模拟疾病。本文将综述利用患者来源的诱导多能干细胞对多种疾病(包括其细胞表型)进行建模的最新进展。本文还将描述研究人员如何利用这些模型来验证药物作为这些破坏性疾病潜在治疗方法的有效性。

相似文献

1
Patient-Specific Induced Pluripotent Stem Cells for Disease Modeling and Phenotypic Drug Discovery.用于疾病建模和表型药物发现的患者特异性诱导多能干细胞。
J Med Chem. 2016 Jan 14;59(1):2-15. doi: 10.1021/acs.jmedchem.5b00789. Epub 2015 Sep 4.
2
Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.人类多能干细胞作为神经退行性疾病和神经发育疾病建模及药物发现的工具。
Expert Opin Drug Discov. 2015 Jun;10(6):615-29. doi: 10.1517/17460441.2015.1037737. Epub 2015 Apr 20.
3
A new era of disease modeling and drug discovery using induced pluripotent stem cells.利用诱导多能干细胞进行疾病建模和药物发现的新时代。
Arch Pharm Res. 2017 Jan;40(1):1-12. doi: 10.1007/s12272-016-0871-0. Epub 2016 Dec 5.
4
Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.利用患者特异性干细胞模型推进神经精神疾病的药物研发。
Mol Cell Neurosci. 2016 Jun;73:104-15. doi: 10.1016/j.mcn.2016.01.011. Epub 2016 Jan 28.
5
Disease-in-a-dish: the contribution of patient-specific induced pluripotent stem cell technology to regenerative rehabilitation.培养皿中的疾病:患者特异性诱导多能干细胞技术对再生康复的贡献
Am J Phys Med Rehabil. 2014 Nov;93(11 Suppl 3):S155-68. doi: 10.1097/PHM.0000000000000141.
6
Stem cells: A path towards improved epilepsy therapies.干细胞:通往改善癫痫治疗的道路。
Neuropharmacology. 2020 May 15;168:107781. doi: 10.1016/j.neuropharm.2019.107781. Epub 2019 Sep 17.
7
Stem cells in pediatric cardiology.儿科心脏病学中的干细胞。
Eur J Pediatr. 2013 Oct;172(10):1287-92. doi: 10.1007/s00431-012-1920-4. Epub 2013 Jan 5.
8
Concise review: Embryonic stem cells versus induced pluripotent stem cells: the game is on.简明回顾:胚胎干细胞与诱导多能干细胞:游戏开始。
Stem Cells. 2012 Jan;30(1):10-4. doi: 10.1002/stem.788.
9
Induced pluripotent stem cells as cardiac arrhythmic in vitro models and the impact for drug discovery.诱导多能干细胞作为心律失常的体外模型及其对药物发现的影响。
Expert Opin Drug Discov. 2014 Jan;9(1):55-76. doi: 10.1517/17460441.2014.863275. Epub 2013 Dec 3.
10
Induced pluripotent stem cell-based studies of Parkinson's disease: challenges and promises.基于诱导多能干细胞的帕金森病研究:挑战与展望。
CNS Neurol Disord Drug Targets. 2013 Dec;12(8):1114-27.

引用本文的文献

1
Current advances and future prospects of cell reprogramming in progeroid syndromes.早衰综合征中细胞重编程的当前进展与未来前景
Front Cell Dev Biol. 2025 Feb 19;13:1546423. doi: 10.3389/fcell.2025.1546423. eCollection 2025.
2
A chemical approach facilitates CRISPRa-only human iPSC generation and minimizes the number of targeted loci required.一种化学方法有助于仅通过CRISPRa技术生成人类诱导多能干细胞,并将所需的靶向基因座数量降至最低。
Future Sci OA. 2024 May 15;10(1):FSO964. doi: 10.2144/fsoa-2023-0257. eCollection 2024.
3
Differentiation of Pluripotent Stem Cells for Disease Modeling: Learning from Heart Development.
用于疾病建模的多能干细胞分化:从心脏发育中汲取经验。
Pharmaceuticals (Basel). 2024 Mar 5;17(3):337. doi: 10.3390/ph17030337.
4
CRISPR and iPSCs: Recent Developments and Future Perspectives in Neurodegenerative Disease Modelling, Research, and Therapeutics.CRISPR 与 iPSCs:神经退行性疾病建模、研究与治疗的最新进展与未来展望。
Neurotox Res. 2022 Oct;40(5):1597-1623. doi: 10.1007/s12640-022-00564-w. Epub 2022 Aug 31.
5
Cell models for Down syndrome-Alzheimer's disease research.用于唐氏综合征-阿尔茨海默病研究的细胞模型。
Neuronal Signal. 2022 Apr 8;6(1):NS20210054. doi: 10.1042/NS20210054. eCollection 2022 Apr.
6
Brain-on-a-Chip: Dream or Reality?芯片大脑:梦想还是现实?
Front Neurosci. 2022 Mar 2;16:837623. doi: 10.3389/fnins.2022.837623. eCollection 2022.
7
Perspective on human pluripotent stem cell-derived cardiomyocytes in heart disease modeling and repair.人类多能干细胞衍生的心肌细胞在心脏病建模和修复中的展望。
Stem Cells Transl Med. 2020 Oct;9(10):1121-1128. doi: 10.1002/sctm.19-0340. Epub 2020 Jul 29.
8
DeepNEU: Artificially Induced Stem Cell (aiPSC) and Differentiated Skeletal Muscle Cell (aiSkMC) Simulations of Infantile Onset POMPE Disease (IOPD) for Potential Biomarker Identification and Drug Discovery.DeepNEU:用于潜在生物标志物鉴定和药物发现的婴儿型庞贝病(IOPD)的人工诱导干细胞(aiPSC)和分化骨骼肌细胞(aiSkMC)模拟。
Front Cell Dev Biol. 2019 Dec 6;7:325. doi: 10.3389/fcell.2019.00325. eCollection 2019.
9
Stem cell-derived retinal pigment epithelium from patients with age-related macular degeneration exhibit reduced metabolism and matrix interactions.源自年龄相关性黄斑变性患者的干细胞衍生的视网膜色素上皮细胞表现出代谢和基质相互作用减少。
Stem Cells Transl Med. 2020 Mar;9(3):364-376. doi: 10.1002/sctm.19-0321. Epub 2019 Dec 16.
10
Nanotopography-responsive myotube alignment and orientation as a sensitive phenotypic biomarker for Duchenne Muscular Dystrophy.纳米形貌响应性肌管排列和取向作为杜氏肌营养不良症的敏感表型生物标志物。
Biomaterials. 2018 Nov;183:54-66. doi: 10.1016/j.biomaterials.2018.08.047. Epub 2018 Aug 21.